HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyoji Furuta Selected Research

NEPP11 compound

10/2009GIF-0173 protects against cerebral infarction through DP1 receptor activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyoji Furuta Research Topics

Disease

5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 10/2009
4Parkinson Disease (Parkinson's Disease)
01/2022 - 10/2009
3Hyperalgesia
06/2013 - 12/2007
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 01/2022
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2018
2Melanoma (Melanoma, Malignant)
12/2021 - 01/2019
2Glioma (Gliomas)
04/2021 - 10/2012
2Pain (Aches)
06/2013 - 12/2007
2Gyrate Atrophy
03/2011 - 01/2007
1Proteostasis Deficiencies
01/2022
1Cognitive Dysfunction
01/2022
1Spinal Cord Diseases
01/2022
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2022
1Pheochromocytoma
04/2021
1Melanosis (Freckles)
01/2019
1Hyperpigmentation
01/2019
1Manganese Poisoning
10/2009
1Cerebral Infarction
10/2009
1Thrombosis (Thrombus)
10/2009
1Brain Ischemia (Cerebral Ischemia)
10/2009
1Infarction (Infarctions)
10/2009
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2009
1Necrosis
10/2009
1Neuralgia (Stump Neuralgia)
12/2007

Drug/Important Bio-Agent (IBA)

42-oxindole (oxindole)IBA
01/2022 - 01/2020
3acromelic acid AIBA
06/2013 - 12/2007
2Messenger RNA (mRNA)IBA
04/2021 - 03/2011
2AcidsIBA
06/2013 - 12/2007
2PoisonsIBA
06/2013 - 12/2007
2(2S,3R,4R)- 3- carboxymethyl- 4- (phenylthio)pyrrolidine- 2- carboxylic acidIBA
06/2013 - 12/2007
2cyclopentenoneIBA
10/2012 - 10/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2011 - 12/2007
2Transaminases (Aminotransferases)IBA
03/2011 - 01/2007
2Retinal Pigments (Pigments, Visual)IBA
03/2011 - 01/2007
2OrnithineIBA
03/2011 - 01/2007
2Glutamic Acid (Glutamate)FDA Link
10/2009 - 12/2007
1Protein AggregatesIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1PrionsIBA
01/2022
1Amyloidogenic ProteinsIBA
01/2022
1OxindolesIBA
12/2021
1CurcuminIBA
04/2021
1ThionesIBA
01/2019
1Melanins (Melanin)IBA
01/2019
1ThioamidesIBA
01/2019
1Dihydrotachysterol (AT 10)IBA
06/2013
1Kainic Acid (Kainate)IBA
06/2013
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
06/2013
1UBP296IBA
06/2013
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2012
1Nerve Growth Factors (Neurotrophins)IBA
10/2012
1ProstaglandinsIBA
10/2012
1pyrrolidineIBA
04/2011
1ArginaseIBA
03/2011
1Dopamine (Intropin)FDA LinkGeneric
10/2009
1Neuroprotective AgentsIBA
10/2009
1NEPP11 compoundIBA
10/2009
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
12/2007
1Analgesics (Analgesic Drugs)IBA
12/2007
1N-Methylaspartate (NMDA)IBA
12/2007
1NADPH Dehydrogenase (Dehydrogenase, NADP)IBA
12/2007

Therapy/Procedure

2Therapeutics
01/2022 - 01/2018